The Institute was set up as a legal entity in Spring 2018, later becoming a registered charity. The board for the Institute, also acting as its trustees, will be made up of members nominated by member organisations, plus representation from industry and affiliated organisations.
There are several layers of governance which control the finances and decision making at the Institute.
The Board of Directors – the board are the trustees for the charity, with legal responsibilities to ensure the safe and effective management of the Institute.
Member representatives – this group represent the interests of the member organisations, and their role is to ensure that the institute is delivering strong partnerships with its members.
The Value for Money Panel – this panel consider all major funding decisions, and assess their viability and value for money. Only proposals with the support of the Executive Team and relevant Theme Advisory Panels will be submitted to the Value for Money panel.
The Executive Team – the executive is made up of the senior leadership team for the Institute, plus the theme leaders. They consider developments across the themes and form part of the decision making in advancing proposals to the Value for Money Panel.
Strategic Advisory Board – has been established to advise the Franklin, via its Board on the development and implementation of the research and development strategy of the institute. Members are independent experts from academia and industry, both national and international. The SAB met for the first time in February 2020 and reviewed the current direction and future plans for each theme.
Theme Advisory Panels – each theme has a panel of international experts from across academia and industry who contribute to the development and review of the road-maps and technology proposals for each theme.
Board of Directors
Professor Paul Matthews
Institute Director
Paul Matthews is the Director of the Rosalind Franklin Institute, Edmond and Lily Safra Professor of Translational Neuroscience and Therapeutics […]
Dr Vivienne Cox
Chair
Dr Vivienne Cox was appointed as Chair of the Rosalind Franklin Institute in 2018. A chemistry graduate with a passion […]
Caroline Carter
Board member
Caroline is a non-practicing solicitor of the senior courts; formerly a senior equity partner in global law firm Ashurst LLP, […]
Bruce Pritchard
Board member
Bruce is a seasoned private company Chair and Non-Executive Director with Remuneration and Chair of Audit Committee experience. He is […]
Hilary Newiss
Board member
Hilary is an experienced non-executive Director in the fields of science, innovation, creativity and health, particularly on the intersection between […]
Dr Malcolm Skingle
Board member
Malcolm has a BSc in Pharmacology/Biochemistry and PhD in Neuropharmacology and has over 70 publications including articles on the interface […]
Dr David Rees
Board Member, Astex Pharmaceuticals
David is Chief Scientific Officer at Astex Pharmaceuticals, Cambridge UK. He is associated with the discovery of three launched drugs, […]
Professor Mathias Gautel
Board Member, King’s College London
Mathias is the BHF Professor of Molecular Cardiology at King’s College London, whose research is focused the contractile structures of […]
Dr Gillian Burgess
Board Member, Grünenthal
Gillian Burgess joined Grünenthal as Head of Research in April 2020. Prior to this she was the Vice President, Site Head […]
Dr Barbara Ghinelli
Board Member - UKRI-STFC
Barbara is Harwell Campus Business Development Director at UKRI-STFC, where she oversees the development and management of clusters on the […]
Professor Nigel Titchener-Hooker
Board Member, UCL
Professor Nigel Titchener-Hooker, CENg, FIChemE, FREng is Dean of UCL Engineering and was for the past 7 years head of […]